These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 26083546)

  • 1. Clinical Impact of Rapid Reduction of Low-Density Lipoprotein Cholesterol Level on Long-Term Outcome of Acute Myocardial Infarction in the Statin Era: Subanalysis of the ALPS-AMI Study.
    Miura T; Izawa A; Motoki H; Miyashita Y; Kashima Y; Ebisawa S; Tomita T; Koyama J; Ikeda U
    PLoS One; 2015; 10(6):e0127835. PubMed ID: 26083546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of the statin escape phenomenon on long-term clinical outcomes in patients with acute myocardial infarction: Subgroup analysis of the Nagoya Acute Myocardial Infarction Study (NAMIS).
    Ota T; Ishii H; Suzuki S; Shibata Y; Tatami Y; Harata S; Shimbo Y; Takayama Y; Tanaka A; Kawamura Y; Osugi N; Maeda K; Kondo T; Murohara T
    Atherosclerosis; 2015 Sep; 242(1):155-60. PubMed ID: 26188539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between low-density lipoprotein levels on admission and 1-year outcome in patients with acute ST-segment-elevation myocardial infarction.
    Sun YJ; Li YZ; Jiang DM; Zhang B; Gao Y; Zhang ZH; Qi GX
    Kaohsiung J Med Sci; 2013 Apr; 29(4):206-13. PubMed ID: 23541266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Benefits of Statin Therapy in Patients With Acute Myocardial Infarction With Serum Low-Density Lipoprotein Cholesterol ≤ 50 mg/dl.
    Piao ZH; Jin L; Kim JH; Ahn Y; Kim YJ; Cho MC; Kim CJ; Kim HS; Liu B; Jeong MH;
    Am J Cardiol; 2017 Jul; 120(2):174-180. PubMed ID: 28532771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the effects of two low-density lipoprotein cholesterol goals for secondary prevention after acute myocardial infarction in real-world practice: ≥ 50% reduction from baseline versus <70 mg/dL.
    Cho KH; Jeong MH; Park KW; Kim HS; Lee SR; Chae JK; Hong YJ; Kim JH; Ahn Y; Cho JG; Park JC;
    Int J Cardiol; 2015; 187():478-85. PubMed ID: 25846658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relation between paradoxical decrease in high-density lipoprotein cholesterol levels after statin therapy and adverse cardiovascular events in patients with acute myocardial infarction.
    Ota T; Ishii H; Suzuki S; Tanaka A; Shibata Y; Tatami Y; Harata S; Shimbo Y; Takayama Y; Kawamura Y; Osugi N; Maeda K; Kondo T; Murohara T
    Am J Cardiol; 2015 Feb; 115(4):411-6. PubMed ID: 25555656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benefit of early statin therapy in patients with acute myocardial infarction who have extremely low low-density lipoprotein cholesterol.
    Lee KH; Jeong MH; Kim HM; Ahn Y; Kim JH; Chae SC; Kim YJ; Hur SH; Seong IW; Hong TJ; Choi DH; Cho MC; Kim CJ; Seung KB; Chung WS; Jang YS; Rha SW; Bae JH; Cho JG; Park SJ;
    J Am Coll Cardiol; 2011 Oct; 58(16):1664-71. PubMed ID: 21982310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is non-HDL-cholesterol a better predictor of long-term outcome in patients after acute myocardial infarction compared to LDL-cholesterol? : a retrospective study.
    Wongcharoen W; Sutthiwutthichai S; Gunaparn S; Phrommintikul A
    BMC Cardiovasc Disord; 2017 Jan; 17(1):10. PubMed ID: 28056802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A 52-week, randomized, open-label, parallel-group comparison of the tolerability and effects of pitavastatin and atorvastatin on high-density lipoprotein cholesterol levels and glucose metabolism in Japanese patients with elevated levels of low-density lipoprotein cholesterol and glucose intolerance.
    Sasaki J; Ikeda Y; Kuribayashi T; Kajiwara K; Biro S; Yamamoto K; Ageta M; Kobori S; Saikawa T; Otonari T; Kono S
    Clin Ther; 2008 Jun; 30(6):1089-101. PubMed ID: 18640465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Statin Treatment and Low-Density Lipoprotein-Cholesterol on Short-Term Mortality in Acute Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention - Multicenter Registry From Tokyo CCU Network Database.
    Miura M; Yamasaki M; Uemura Y; Yoshikawa M; Miyauchi K; Tanaka H; Miyachi H; Yamashita J; Suzuki M; Yamamoto T; Nagao K; Komuro I; Takayama M
    Circ J; 2016; 80(2):461-8. PubMed ID: 26658282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High high-density lipoprotein-cholesterol reduces risk and extent of percutaneous coronary intervention-related myocardial infarction and improves long-term outcome in patients undergoing elective percutaneous coronary intervention.
    Sattler KJ; Herrmann J; Yün S; Lehmann N; Wang Z; Heusch G; Sack S; Erbel R; Levkau B
    Eur Heart J; 2009 Aug; 30(15):1894-902. PubMed ID: 19474052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prognostic value of very low admission LDL-cholesterol levels in ST-segment elevation myocardial infarction compared in statin-pretreated and statin-naive patients undergoing primary percutaneous coronary intervention.
    Oduncu V; Erkol A; Kurt M; Tanboğa IH; Karabay CY; Şengül C; Bulut M; Özveren O; Fotbolcu H; Akgün T; Türkyilmaz E; Kırma C
    Int J Cardiol; 2013 Jul; 167(2):458-63. PubMed ID: 22305817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C-reactive protein levels and outcomes after statin therapy.
    Ridker PM; Cannon CP; Morrow D; Rifai N; Rose LM; McCabe CH; Pfeffer MA; Braunwald E;
    N Engl J Med; 2005 Jan; 352(1):20-8. PubMed ID: 15635109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rationale and design of assessment of lipophilic vs. hydrophilic statin therapy in acute myocardial infarction (the ALPS-AMI) study.
    Kashima Y; Izawa A; Aizawa K; Koshikawa M; Kasai H; Tomita T; Kumazaki S; Tsutsui H; Koyama J; Ikeda U
    J Cardiol; 2009 Aug; 54(1):76-9. PubMed ID: 19632524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-density lipoprotein cholesterol level in patients with acute myocardial infarction having percutaneous coronary intervention (the cholesterol paradox).
    Cho KH; Jeong MH; Ahn Y; Kim YJ; Chae SC; Hong TJ; Seong IW; Chae JK; Kim CJ; Cho MC; Seung KB; Park SJ;
    Am J Cardiol; 2010 Oct; 106(8):1061-8. PubMed ID: 20920639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term safety and efficacy of Pitavastatin in patients with acute myocardial infarction (from the Livalo Acute Myocardial Infarction Study [LAMIS]).
    Suh SY; Rha SW; Ahn TH; Shin EK; Choi CU; Oh DJ; Bae JH; Hur SH; Yun KH; Oh SK; Kim JH; Kim SW; Chae IH; Kim KS; Hong YJ; Jeong MH;
    Am J Cardiol; 2011 Dec; 108(11):1530-5. PubMed ID: 21890083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intensity of statin therapy, achieved low-density lipoprotein cholesterol levels and cardiovascular outcomes in Japanese patients after coronary revascularization. Perspectives from the CREDO-Kyoto registry cohort-2.
    Natsuaki M; Furukawa Y; Morimoto T; Nakagawa Y; Ono K; Kaburagi S; Inada T; Mitsuoka H; Taniguchi R; Nakano A; Kita T; Sakata R; Kimura T;
    Circ J; 2012; 76(6):1369-79. PubMed ID: 22447012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of the addition of ezetimibe to ongoing statin therapy in modifying lipid profiles and attaining low-density lipoprotein cholesterol goals in older and elderly patients: subanalyses of data from a randomized, double-blind, placebo-controlled trial.
    Pearson T; Denke M; McBride P; Battisti WP; Brady WE; Palmisano J
    Am J Geriatr Pharmacother; 2005 Dec; 3(4):218-28. PubMed ID: 16503317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Failure to achieve recommended LDL cholesterol levels by suboptimal statin therapy relates to elevated cardiac event rates.
    Baessler A; Fischer M; Huf V; Mell S; Hengstenberg C; Mayer B; Holmer S; Riegger G; Schunkert H
    Int J Cardiol; 2005 May; 101(2):293-8. PubMed ID: 15882678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A 50-week extension study on the safety and efficacy of colesevelam in adults with primary hypercholesterolemia.
    Davidson MH; Donovan JM; Misir S; Jones MR
    Am J Cardiovasc Drugs; 2010; 10(5):305-14. PubMed ID: 20860413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.